Skip to main content
Fig. 4 | Biomaterials Research

Fig. 4

From: Controlled release of Clenbuterol from a hydroxyapatite carrier for the treatment of Alzheimer’s Disease

Fig. 4

Impact of CLB on the aggregation of Aβ was investigated through various experiments. (A) Aβ fibril formation was tracked using ThT fluorescence to measure the fluorescence intensity. (B) Fluorescence intensity at different concentrations of CLB was measured and analyzed. The data was obtained from six independent experiments, and statistical analysis revealed significant differences (n = 6, ** P < 0.01 compared with the control, *** P < 0.001 compared with the control). (C) TEM was used to capture images of negatively stained samples collected at atmospheric pressure

Back to article page

Biomaterials Research

ISSN: 2055-7124

Contact us